Next 10 |
home / stock / iscnf / iscnf news
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) announces that further to its news release dated September 29, 2022 (the “ Default Announcement ”), the Comp...
VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) announces that the filing of its audited annual financial statements for the year ended May 31, 2022, including the related m...
VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor i...
Isracann Biosciences ( OTCPK:ISCNF ) has announced that it has facilitated its first shipment of cannabis strains to Israel. The agreement for genetics is directly between United Greeneries, a licensed Canadian producer of high calibre craft cannabis, and Intelicanna, a licens...
VANCOUVER, British Columbia, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”), a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor,...
VANCOUVER, British Columbia, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel,...
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) a multi-faceted organization with a natural health medicine division (Praesidio Health) in Canada and holdings in Israel, ...
VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that it has closed the first tranche of its previously announced non-brokered private placement. The Co...
VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) a multi-faceted organization with a natural health medicine division in Canada and holdings in Israel, is pleased to announ...
VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) is pleased to announce that further to its acquisition of Praesidio Health Inc. as a natural health medicine division, th...
News, Short Squeeze, Breakout and More Instantly...
Isracann Biosciences Company Name:
ISCNF Stock Symbol:
OTCMKTS Market:
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) announces that further to its news release dated September 29, 2022 (the “ Default Announcement ”), the Comp...
VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) announces that the filing of its audited annual financial statements for the year ended May 31, 2022, including the related m...
VANCOUVER, British Columbia, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “ Company ”) a multi-faceted Israel-based company focused on becoming a premier low cost, high quality cannabis producer/distributor i...